LRRC15 and neoplasm: Recently, a study demonstrated that leucine rich repeat containing 15 (LRRC15) displayed a more specific expression pattern in myCAFs, and targeted depletion of LRRC15+ myCAFs resulted in a substantial 70% reduction in overall PDPN+ CAFs, significantly attenuating PDAC tumour growth [216].